Unity Biotechnology (UBX) Cash on Hand per Share

Corporate emblem and logo of unitybiotechnology.com (UBX)

Cash per share dynamics demonstrate the liquidity of Unity Biotechnology (UBX), which develops senolytics to combat joint and eye aging. The value of 0.00 reflects this status. Drug production relies on third-party contractors in the US, which minimizes technical risks. Operations are strictly regulated by FDA standards, including biological waste disposal rules.

UBX - Unity Biotechnology Cash Funds per Share over the range 07/04/2022 - 07/19/2025

Analytical breakdowns for Unity Biotechnology, Inc (UBX)

- current price and projected stock value:
- market capitalization details:
- cash position and cash flow details:
General company analysis:UBX, Unity Bio
Mass-produced product of Unity Bio

Unity Biotechnology minimizes capital expenditures by outsourcing production and testing to third-party contractors. This model renders liquidity a critical resource for paying contract services. This metric is calculated as the ratio of total cash to the number of shares outstanding. It determines the real value of the liquid reserve per share, assessing the company's financial stability. The trend of cash per share reflects the balance between crisis protection and inflationary risks.

Key competitors

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|Cash per Share Singular Genomics Systems, Inc. (OMIC)|Cash per Share RGLS (Regulus Therapeutics, Inc.)|Cash per Share Syros SYRS|Telesis Bio, Inc. - Cash per Share|TRACON Pharmaceuticals (TCON) - Cash per Single Share